2 Cannabis Stocks That Will More Than Double in 2022, According to Wall Street Analysts

: CURLF | Curaleaf Holdings, Inc. News, Ratings, and Charts

CURLF – The surge in cannabis sales due to innovative cannabis products and the growing support regarding the legalization of cannabis at a federal level should allow the cannabis industry to rebound rapidly next year. Therefore, Wall Street analysts expect cannabis stocks Curaleaf (CURLF) and Zynerba (ZYNE) to be more than double in 2022.

The increasing requirement of cannabidiol oil for therapeutic needs from the aging population and changes in consumer preferences towards innovative recreational cannabis products have been driving the cannabis industry’s growth. Moreover, the government is expected to soon legalize cannabis at a federal level, backed by several Democrats and Republicans. The U.S. cannabis industry is growing at an unprecedented pace, and cannabis sales are estimated to increase 41% year-over-year to finish 2021 at $31 billion.

As of November 2021, 180 bipartisan Members of Congress, 39 bipartisan Senators, and Governors from 21 states and territories supported the SAFE Banking Act.  Furthermore, as of January 2021, 321,000 full-time American jobs supported by legal cannabis have also created a positive outlook surrounding the cannabis market.

Given this backdrop, Wall Street analysts expect cannabis stocks Curaleaf Holdings, Inc. (CURLF) and Zynerba Pharmaceuticals, Inc. (ZYNE) to gain substantial momentum in the near term.

Curaleaf Holdings, Inc. (CURLF)

CURLF is a vertically integrated cannabis operator in the United States that researches and develops capabilities to distribute cannabis products. The company operates in two segments- Cannabis Operations; and Non-Cannabis Operations. Through its Curaleaf Hemp brand, the company provides service across the medical and adult-use markets and the cannabidiol (CBD) category.

This month, CURLF has planned to open four new dispensaries in Florida by the end of this year. This expansion should increase the CURLF’s retail footprint to 42 dispensaries statewide and 117 across the country. The company has also planned to launch new products in the Florida market next year.

CURLF’s total revenue for the third quarter ended September 30, 2021, increased 73.9% year-over-year to $317.13 million. The company’s gross profit grew 57.8% from the year-ago value to $182.73 million. Its income from operations rose 144.3% from the prior-year quarter to $39.99 million. Also, the company’s adjusted EBITDA increased 68.7% year-over-year to $71.36 million.

CURLF’s revenue is expected to increase 34.3% year-over-year to $1.64 billion in fiscal 2022. Its EPS is expected to grow 20% per annum in the next five years.

Closing the last trading session at $8.6, the average analyst price target of $18.59 represents a 116.2% potential upside.

Zynerba Pharmaceuticals, Inc. (ZYNE)

Incorporated in 2007, ZYNE develops next-generation transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. The company’s lead product candidate, Zygel (ZYN002 CBD Gel), is a cannabidiol (CBD) gel for FXS, ASD in pediatric patients, 22q, and a heterogeneous group of rare epilepsies known as DEE.

In November, ZYNE announced that the European Patent Office issued the patent titled “Treatment of Fragile X Syndrome and Autism with Cannabidiol.” This patent includes claims directed to methods of treating one or more behavioral symptoms of Fragile X syndrome. Also, this new patent is a part of an expanding international intellectual property portfolio covering ZYNE’s transdermal cannabidiol product candidate, Zygel CBD gel.

During the third quarter ended September 30, 2021, ZYNE’s interest income came in at $5.04 thousand. The company’s loss per share decreased 16.1% year-over-year to $0.26. Its cash and cash equivalents grew 27.9% to $75.64 million for the nine months ended September 30, 2021.

ZYNE’s EPS is estimated to grow 48.4% in the current year.

The consensus price target of $9 represents a 180.4% potential gain from the last closing price of $3.21.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


CURLF shares were trading at $8.98 per share on Thursday afternoon, up $0.38 (+4.38%). Year-to-date, CURLF has declined -24.99%, versus a 27.70% rise in the benchmark S&P 500 index during the same period.


About the Author: Priyanka Mandal


Priyanka is a passionate investment analyst and financial journalist. After earning a master's degree in economics, her interest in financial markets motivated her to begin her career in investment research. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CURLFGet RatingGet RatingGet Rating
ZYNEGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Does Trump Change Stock Market Outlook?

The rally of the S&P 500 (SPY) after the election gives a sense that investors are happy that Trump was elected. But perhaps there is more to this story than meets the eye. That’s why Steve Reitmeister shares his updated market outlook taking into account the pros and cons of Trumps proposed new policies. This comes with a preview of his top 11 stocks to buy now.

3 Streaming Stocks Benefiting from Cord-Cutting Trends

As streaming continues to dominate the digital entertainment landscape, the global streaming market presents a lucrative investment opportunity. So, it could be ideal to invest in fundamentally solid streaming stocks Netflix (NFLX), Walt Disney (DIS), and Roku (ROKU). Read further...

3 Gold Stocks to Buy as Safe-Haven Demand Grows

Gold is a stable investment now due to its role as a safe-haven asset during economic uncertainty, rising demand, industrial use, and growth, bolstered by central bank purchases and interest rate cuts. Therefore, investors should consider investing in top gold stocks such as Newmont (NEM), Barrick Gold (GOLD), and Agnico Eagle Mines (AEM). Read more...

3 AI Stocks Transforming Industries and Driving Future Growth

With rapid digitalization, rapid adoption, and development, as well as surging demand, the AI market is on the rise. Amid this backdrop, investors could buy fundamentally solid AI stocks NVIDIA Corporation (NVDA), Microsoft (MSFT), and Meta Platforms (META) poised for substantial gains. Continue reading...

Updated Stock Market Expectations

The S&P 500 (SPY) has already reached an impressive goal of hitting 6,000. Yet you can see how much shares are struggling now up against this resistance. Steve Reitmeister shares his views on what comes next for the market and his top 10 stocks to stay on the right side of the action.

Read More Stories

More Curaleaf Holdings, Inc. (CURLF) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CURLF News